UnitedHealth Stock Slips Amid Investor Lawsuit
UnitedHealth Group Inc.'s stock price dipped by 1.61% on August 14, 2026, to $399.06 after a fresh investor lawsuit emerged as the day's main catalyst.
The lawsuit puts governance back at the center of the UnitedHealth Group story and adds friction to the already meaningful recovery in the shares.
UnitedHealth reported adjusted earnings per share (EPS) of $6.38 for the quarter ending July 16, 2026, exceeding consensus estimates of $4.94, with revenue rising 0.4% year-over-year.
The company projected 2026 adjusted EPS between $19.50 and $20, while operating earnings increased by 55% year over year in the second quarter.
Investors are likely to focus on whether the 2026 earnings range stays intact as litigation noise builds, with a consensus rating of Moderate Buy and a price target of $455.92 currently in place.